tradingkey.logo

Rein Therapeutics Inc <RNTX.OQ> expected to post a loss of 24 cents a share - Earnings Preview

ReutersMay 9, 2025 9:46 PM
  • Rein Therapeutics Inc RNTX.OQ RNTX.O is expected to show no change in quarterly revenue when it reports results on May 13 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Rein Therapeutics Inc is for a loss of 24 cents per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 71.0% in the last three months. ​

  • Wall Street's median 12-month price target for Rein Therapeutics Inc is $10.00​, above​ its last closing price of $1.72. ​​​

This summary was machine generated May 9 at 21:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI